May 23rd, 2022 - SAN DIEGO – An intestinal absorbant, polymethylsiloxane polyhydrate (PMSPH), may relieve the diarrhea associated with irritable bowel syndrome (IBS), researchers say. The absorbant reduced abdominal pain, improved stool consistency, and won praise from patients, said Yan Yiannakou, MBChB, a consultant in gastroenterology at County Durham and Darlington (England) National Health Service Foundati.

May 23rd, 2022 - Contraceptive counseling and interventions beyond usual care significantly increased the use of contraceptives with no accompanying increase in sexually transmitted infections or reduction in condom use, based on data from a new meta-analysis. “Although effective contraception is available in the United States and guidelines support contraceptive care in clinical practice, providing contracepti.

May 23rd, 2022 - Everything in medicine, and pretty much the universe, is based on averages. Average reduction of seizures, average blood levels, average response to treatment, average insurance reimbursement, average time spent with a new consult.

May 23rd, 2022 - Patients who have paclitaxel-coated stents and balloons have survival and outcomes comparable to those who have a bare-metal stent or percutaneous transluminal angioplasty, according to updated results from a large study of almost 170,000 Medicare beneficiaries. The SAFE-PAD study analyzed Medicare claims data of 168,533 patients, including 70,584 who were treated with drug-coated devices (DCD).

May 23rd, 2022 - SAN DIEGO – When the Food and Drug Administration gave the nod to a first-in-class tissue removal device in July of 2021, clearance was limited to the treatment of moderate to severe wrinkles in the mid to lower face. But once the device – Ellacor– becomes available in late 2022, potential applications are likely to be wide-ranging, Jill S.

May 23rd, 2022 - A clinical practice guideline for the diagnosis and management of gastrointestinal hamartomatous polyposis syndromes has just been published by the U. S.

May 23rd, 2022 - Key clinical point: The prevalence of migraine is higher in children and adolescents with attention deficit hyperactivity disorder (ADHD) vs those without. Major finding: The risk of developing migraine was significantly higher in patients with ADHD than in matched controls (adjusted hazard ratio [aHR] 1.

May 23rd, 2022 - When it comes to picking a summer camp for kids, logistics top the checklist for most parents, a new national poll suggests. And while families consider health and safety information, such as camp supervision and first aid training, less than half of parents rate general safety policies as essential to their camp decision, according to the University of Michigan Health C.S. Mott Children’s Hosp...

May 23rd, 2022 - Madrid, Spain – 23 May 2022: Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease, according to a study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).1 The glycaemic index (GI) ranks carbohydrate-containing foods according to how quickly they affect blood sugar levels. High G...

May 22nd, 2022 - SAN DIEGO – An analysis of a large, international cohort suggests that treatment with protease-inhibitor (PI)–based direct-acting antivirals (DAAs) may be safe for patients with hepatitis C virus (HCV) with cirrhosis and early-stage liver decompensation. The study relied on data from the REAL-C registry, including 935 patients treated with oral DAAs at 27 centers in the U.

May 22nd, 2022 - SAN DIEGO – Treating people with alcoholic hepatitis for alcohol abuse may reduce their risk of hospital readmission, researchers reported. In a retrospective analysis of nationwide data, 7.

May 22nd, 2022 - Madrid, Spain – 22 May 2022: Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 “This study adds to the body of evidence that a more cautious approach to alcohol consumption is needed,” said study author D...

May 22nd, 2022 - Friday, May 20, 2022 (San Diego, U.S.)—Research from the University of California released in Clinical Infectious Diseases demonstrates that ingestible sensor-enabled Truvada®, taken as pre-exposure prophylaxis to prevent HIV infection (PrEP), can reveal patterns of medication taking behavior that may put persons at risk of prophylactic failure. The FDA-approved system, consisting of an ingesti...

May 21st, 2022 - A voice can carry a long distance, but in patients with heart failure (HF) a voice can also carry otherwise hidden signs useful for predicting short-term risk for worsening disease, even acute decompensation. Potentially, it only has to reach a smartphone to do it, suggests a preliminary study of a mobile app designed to alert patients and clinicians to such looming HF events, if possible in ti...

May 21st, 2022 - Madrid, Spain – 21 May 2022: Unmarried heart failure patients appear less confident in managing their condition and more socially limited compared to their married counterparts, according to research presented today at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 These differences may have contributed to the worse long-term survival observed in unmarri...

May 21st, 2022 - Madrid, Spain – 21 May 2022: Life-threatening arrhythmias are more common on days with highly polluted air, according to research presented today at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 The study was conducted in patients with an implantable cardioverter defibrillator (ICD), enabling the authors to track the occurrence of arrhythmias and delive...

May 21st, 2022 - Madrid, Spain – 21 May 2022: A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late breaking research is presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 “The current standard of care just isn’t good enough fo...

May 21st, 2022 - New evidence shows that people who have undergone Gender Affirming Hormone Therapy report high grades of satisfaction with both the physical and psychological effects. A new study on this topic, carried out by researchers in Portugal, will be presented today (21 May 2022) at the 24th European Congress of Endocrinology in Milan, Italy. Gender Affirming Hormone Therapy (GAHT) aims to align the ch...

May 20th, 2022 - A balance between fear and relaxation is normal. However, mental dispositions and the continuous influence of environmental stimuli can disrupt this balance.

May 20th, 2022 - Qualitative interviews with a group of female physicians identified several concerns about fertility and family planning and how those concerns affected their career choices. Among the findings in a new study were that all 16 women interviewed said medical school education surrounding fertility was inadequate.